Healius Limited – Panel Declines to Conduct Proceedings

The Panel has declined to conduct proceedings on an application dated 28 March 2023 from Healius Limited (Healius) in relation to its affairs.

Healius is currently the subject of an off‑market scrip takeover bid made by Australian Clinical Labs Limited (ACL) and the application primarily concerned the contents of the Bidder’s Statement lodged in connection with the bid (see TP23/013).